457 related articles for article (PubMed ID: 30805320)
1. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development.
Arai A
Front Pediatr; 2019; 7():14. PubMed ID: 30805320
[TBL] [Abstract][Full Text] [Related]
2. Chronic active Epstein-Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements.
Arai A
Immunol Med; 2018 Dec; 41(4):162-169. PubMed ID: 30704352
[TBL] [Abstract][Full Text] [Related]
3. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
4. [The road to treating chronic active Epstein-Barr viral infection].
Arai A
Rinsho Ketsueki; 2021; 62(7):835-845. PubMed ID: 34349069
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features of adult-onset chronic active Epstein-Barr virus infection].
Kawamoto K; Miyoshi H; Seto M; Kimura H; Ohshima K
Rinsho Ketsueki; 2019; 60(8):944-952. PubMed ID: 31484894
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders.
Sawada A; Inoue M
Front Pediatr; 2018; 6():334. PubMed ID: 30460216
[TBL] [Abstract][Full Text] [Related]
8. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T
Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349
[TBL] [Abstract][Full Text] [Related]
9. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
Xiao H; Hu B; Luo R; Hu H; Zhang J; Kuang W; Zhang R; Li L; Liu G
Virol J; 2020 Oct; 17(1):166. PubMed ID: 33121509
[TBL] [Abstract][Full Text] [Related]
10. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
[TBL] [Abstract][Full Text] [Related]
11. STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target.
Onozawa E; Shibayama H; Takada H; Imadome KI; Aoki S; Yoshimori M; Shimizu N; Fujiwara S; Koyama T; Miura O; Arai A
Oncotarget; 2018 Jul; 9(57):31077-31089. PubMed ID: 30123428
[TBL] [Abstract][Full Text] [Related]
12. Chronic Active Epstein-Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
Fujiwara S; Nakamura H
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33143184
[TBL] [Abstract][Full Text] [Related]
13. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
[TBL] [Abstract][Full Text] [Related]
14. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
17. Current research on chronic active Epstein-Barr virus infection in Japan.
Fujiwara S; Kimura H; Imadome K; Arai A; Kodama E; Morio T; Shimizu N; Wakiguchi H
Pediatr Int; 2014 Apr; 56(2):159-66. PubMed ID: 24528553
[TBL] [Abstract][Full Text] [Related]
18. Updated guidelines for chronic active Epstein-Barr virus disease.
Kawada JI; Ito Y; Ohshima K; Yamada M; Kataoka S; Muramatsu H; Sawada A; Wada T; Imadome KI; Arai A; Iwatsuki K; Ohga S; Kimura H;
Int J Hematol; 2023 Nov; 118(5):568-576. PubMed ID: 37728704
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.
Xiao HJ; Li J; Song HM; Li ZH; Dong M; Zhou XG
Medicine (Baltimore); 2016 Feb; 95(5):e2676. PubMed ID: 26844502
[TBL] [Abstract][Full Text] [Related]
20. Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells.
Wang J; Su M; Wei N; Yan H; Zhang J; Gong Y; Wu L; Suolitiken D; Pi Y; Song D; Chen L; Liu H; Yang S; Wang X; Wang Z
Blood; 2024 Jan; 143(1):32-41. PubMed ID: 37824804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
